rxstat › Shortages › Temozolomide

Temozolomide (Temodal) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Sep 3, 2026

Some Temozolomide products are in shortage in Canada (9 of 23 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 18, 2026.

A chemotherapy medication used to treat certain brain cancers.

Products affected
9 / 23
In shortage since
Jan 14, 2022
Est. full return
Dec 18, 2026
Reports on file
105
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TEMODAL
100MG · CAPSULE · MERCK CANADA INC
DIN 02241095 · since Aug 12, 2026, est. end Sep 11, 2026 · Demand increase for the drug.
Active shortage
JAMP TEMOZOLOMIDE
5MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02516799 · since Aug 26, 2026, est. end Dec 18, 2026 · Allocation - Manufacturer delay
Active shortage
JAMP TEMOZOLOMIDE
20MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02516802 · since Aug 26, 2026, est. end Dec 18, 2026 · Allocation - Manufacturer delay
Active shortage
JAMP TEMOZOLOMIDE
100MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02516810 · since Aug 26, 2026, est. end Dec 18, 2026 · Allocation - Manufacturer delay
Active shortage
JAMP TEMOZOLOMIDE
250MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02516845 · since Aug 26, 2026, est. end Dec 18, 2026 · Allocation - Manufacturer delay
Active shortage
JAMP TEMOZOLOMIDE
140MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02516829 · since Aug 26, 2026, est. end Dec 18, 2026 · Manufacturer delay
Active shortage
TEMODAL
250MG · CAPSULE · MERCK CANADA INC
DIN 02241096 · since Jul 22, 2026, est. end Sep 18, 2026 · Demand increase for the drug.
Active shortage
TEVA-TEMOZOLOMIDE
140MG · CAPSULE · TEVA CANADA LIMITED
DIN 02395290 · since May 6, 2026, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-TEMOZOLOMIDE
5MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02438119 · since Jan 14, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-TEMOZOLOMIDE
5MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02438119 · since Jan 14, 2022, no end estimate · Disruption of the manufacture of the drug.
Anticipated
TEMODAL
5MG · CAPSULE · MERCK CANADA INC
DIN 02241093 · Demand increase for the drug.
Resolved
TEVA-TEMOZOLOMIDE
250MG · CAPSULE · TEVA CANADA LIMITED
DIN 02395312 · ended Aug 20, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Temozolomide is currently affected by 9 active shortage reports filed with Health Canada by MERCK CANADA INC, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, ACCORD HEALTHCARE INC.

The reported causes are: demand increase for the drug; allocation - manufacturer delay; manufacturer delay; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Temozolomide is classified under “ALKYLATINGAGENTS” (ATC L01AX).

Recent changes

Common questions

What is Temozolomide used for?

A chemotherapy medication used to treat certain brain cancers.

When will Temozolomide be back in stock in Canada?

The latest manufacturer estimate is Dec 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Temozolomide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (alkylatingagents)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Buffer Solution Melphalan (Alkeran) No current shortage Bendamustine (Treanda) Partial shortage 2 of 8 reported products affected Busulfan (Myleran) Partial shortage 1 of 4 reported products affected · est. return Oct 23, 2026 Carmustine (Bicnu) Shortage anticipated 0 of 2 reported products affected Dacarbazine Shortage anticipated 0 of 1 reported products affected Cyclophosphamide (Procytox) Widespread shortage 4 of 10 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.